While retroviral transfer of IL-4 did prolong mice survival compared to the control group, it was still significantly less beneficial than introducing the same cytokine using NSCs, suggesting that the intrinsic anti-tumor activity of NSCs may, in part, be responsible for the improvements [63]. Here, IL4 is linked to neoplasm.